ivabradine has been researched along with Triple Negative Breast Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batalha, S; Chan, JYW; Chan, SY; Chan, WL; Chan, YHY; Chau, KM; Gong, C; Khoo, US; Lau, V; Lee, TKW; Leung, JKM; Leung, MH; Luk, MY; Man, EP; Mok, KC; Siu, DCW; Tsoi, H; Wong, LS | 1 |
1 other study(ies) available for ivabradine and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Repurposing hyperpolarization-activated cyclic nucleotide-gated channels as a novel therapy for breast cancer.
Topics: Cell Line; Female; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Triple Negative Breast Neoplasms | 2021 |